Financial Gravity Asset Management, Inc. Biogen Inc. Transaction History

Financial Gravity Asset Management, Inc.

$400 Billion
Q2 2024

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Jun 26, 2024	SELL	$212.02 - $267.71 $424 - $535	-2 Reduced 40.0%	3 $624,000
Q1 2024 May 13, 2024	BUY	$212.02 - $267.71 $424 - $535	2 Added 40.0%	7 $1.41 Million
Q4 2023 Jun 26, 2024	SELL	$222.59 - $267.94 $445 - $535	-2 Reduced 28.57%	5 $1.46 Million
Q3 2023 Nov 15, 2023	SELL	$253.3 - $285.89 $70,924 - $80,049	-280 Reduced 98.25%	5 $1,000
Q2 2023 Aug 08, 2023	BUY	$275.25 - $318.06 $1,926 - $2,226	7 Added 2.52%	285 $1.86 Million
Q1 2023 May 12, 2023	BUY	$256.56 - $292.34 $256 - $292	1 Added 0.36%	278 $3.7 Million
Q4 2022 Feb 15, 2023	SELL	$252.44 - $306.72 $738,891 - $897,769	-2,927 Reduced 91.35%	277 $2 Million
Q3 2022 Nov 03, 2022	BUY	$194.69 - $268.46 $67,752 - $93,424	348 Added 12.18%	3,204 $1.41 Million
Q2 2022 Aug 05, 2022	SELL	$187.54 - $223.02 $18,378 - $21,855	-98 Reduced 3.32%	2,856 $1.08 Million
Q1 2022 May 13, 2022	SELL	$193.77 - $244.14 $125,175 - $157,714	-646 Reduced 17.94%	2,954 $1.11 Million
Q4 2021 Feb 11, 2022	BUY	$223.92 - $287.77 $804,992 - $1.03 Million	3,595 Added 71900.0%	3,600 $1.27 Million
Q3 2021 Nov 12, 2021	SELL	$282.99 - $369.05 $9,055 - $11,809	-32 Reduced 86.49%	5 $283,000
Q2 2021 Aug 11, 2021	SELL	$259.0 - $414.71 $1,295 - $2,073	-5 Reduced 11.9%	37 $346,000
Q1 2021 May 17, 2021	BUY	$242.95 - $284.63 $1,214 - $1,423	5 Added 13.51%	42 $11.7 Million
Q4 2020 Feb 16, 2021	BUY	$236.26 - $355.63 $8,741 - $13,158	37 New	37 $9,000
Q2 2020 Aug 13, 2020	SELL	$258.66 - $342.55 $61,561 - $81,526	-238 Closed	0 $0
Q1 2020 May 12, 2020	SELL	$268.85 - $341.04 $37,370 - $47,404	-139 Reduced 36.87%	238 $75,000
Q4 2019 Feb 28, 2020	SELL	$220.06 - $304.07 $19,585 - $27,062	-89 Reduced 19.1%	377 $297,000
Q3 2019 Oct 15, 2019	SELL	$217.44 - $243.88 $22,613 - $25,363	-104 Reduced 18.25%	466 $109,000
Q2 2019 Jul 26, 2019	SELL	$219.29 - $241.72 $26,753 - $29,489	-122 Reduced 17.63%	570 $133,000
Q1 2019 Apr 19, 2019	SELL	$216.71 - $338.96 $57,211 - $89,485	-264 Reduced 27.62%	692 $161,000
Q3 2018 Oct 31, 2018	BUY	$293.51 - $383.83 $27,589 - $36,080	94 Added 10.9%	956 $288,000
Q2 2018 Aug 14, 2018	SELL	$257.52 - $306.91 $77,256 - $92,073	-300 Reduced 25.82%	862 $295,000
Q1 2018 May 23, 2018	BUY	$260.13 - $367.91 $302,271 - $427,511	1,162 New	1,162 $318,000

Others Institutions Holding BIIB

# of Institutions

1,018

Shares Held

128M

Call Options Held

1.22M

Put Options Held

1.4M

Vanguard Group Inc Valley Forge, PA

16.6M
Shares

$2.88 Billion
0.08% of portfolio
Primecap Management CO Pasadena, CA

16.3M
Shares

$2.84 Billion
2.78% of portfolio
Black Rock Inc. New York, NY

14.5M
Shares

$2.53 Billion
0.08% of portfolio
State Street Corp Boston, MA

7.1M
Shares

$1.23 Billion
0.07% of portfolio
T. Rowe Price Investment Management, Inc. Baltimore, MD

5.68M
Shares

$987 Million
0.83% of portfolio

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Financial Gravity Asset Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Financial Gravity Asset Management, Inc. with notifications on news.

Account